K2M Group Holdings Inc  

(Public, NASDAQ:KTWO)   Watch this stock  
Find more results for K2M, Inc
-0.08 (-0.37%)
Mar 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 21.09 - 21.65
52 week 12.31 - 23.63
Open 21.41
Vol / Avg. 64,498.00/181,440.00
Mkt cap 848.13M
P/E     -
Div/yield     -
EPS -1.75
Shares 39.60M
Beta     -
Inst. own 33%
Mar 24, 2015
K2M Group Holdings Inc at Canaccord Genuity Musculoskeletal Conference
Mar 18, 2015
Q4 2014 K2M Group Holdings Inc Earnings Call - Webcast
Mar 18, 2015
Q4 2014 K2M Group Holdings Inc Earnings Release
Mar 11, 2015
K2M Group Holdings Inc at Barclays Healthcare Conference - Webcast
Mar 4, 2015
K2M Group Holdings Inc at Cowen Health Care Conference - Webcast
Jan 12, 2015
Preliminary Q4 2014 K2M Group Holdings Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -22.44% -31.95%
Operating margin -17.34% -25.70%
EBITD margin - -7.85%
Return on average assets -14.49% -19.89%
Return on average equity -16.98% -29.92%
Employees 448 -
CDP Score - -


751 Miller Drive Se
United States - Map
+1-703-7773155 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


K2M Group Holdings, Inc. (K2M) is a global medical device company focused on designing, developing and commercializing spine technologies and techniques. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor. Its products consist of implants, disposables and instruments which are marketed and sold primarily to hospitals for use by spine surgeons. In addition, the Company invests in the design, development and commercialization of solutions for clinical needs in the spine and minimally invasive spine (MIS) markets. The Company markets and sells its products in the United States and 28 other countries. The Company�s products are used for Complex Spine, MIS and Degenerative Spine. The Company�s technologies include MESA, Rail 4D, Deformity Cricket, SERENGETI, RAVINE, EVEREST and tifix.

Officers and directors

Daniel A. Pelak Chairman of the Board
Age: 62
Bio & Compensation  - Reuters
Eric D. Major President, Chief Executive Officer, Director
Age: 45
Bio & Compensation  - Reuters
Gregory S. Cole CPA Chief Financial Officer
Age: 44
Bio & Compensation  - Reuters
Kostuik P. John Chief Medical Officer, Director
Age: 77
Bio & Compensation  - Reuters
Brett P. Brodnax Director
Age: 50
Bio & Compensation  - Reuters
Carlos A. Ferrer Director
Age: 57
Bio & Compensation  - Reuters
Paul B. Queally Director
Age: 50
Bio & Compensation  - Reuters
Sean M. Traynor Director
Age: 45
Bio & Compensation  - Reuters
Raymond A. Ranelli Independent Director
Age: 67
Bio & Compensation  - Reuters